TransMedics Group, Inc. (TMDX) return on equity (ROE)

Return on equity · fiscal 2025
40.2%

TransMedics Group, Inc. (TMDX) earned a return on equity of 40.2% in fiscal 2025 (the year ended December 31, 2025). That is 24.7 percentage points higher than the 15.5% of fiscal 2024. Figures as of 17 Nov 2026, 23:47 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
40.2%
Change on fiscal 2024
+24.7 pts
Highest on record
40.2%fiscal 2025
Lowest on record
-65.2%fiscal 2021
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

TransMedics Group, Inc. return on equity (ROE), in more detail

Across the 7 fiscal years on record (2019–2025), the highest was 40.2% in fiscal 2025 and the lowest -65.2% in fiscal 2021. The fiscal 2025 figure is higher than in every one of the 6 earlier fiscal years on record, whose median is -23.5%.

History · 7 fiscal years

Return on equity by fiscal year

TransMedics Group, Inc. return on equity (ROE), year by year

TransMedics Group, Inc. (TMDX) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202540.2% 24.7 pts up
202415.5% 33.8 pts up
2023-18.2% 1.1 pts up
2022-19.3% 45.8 pts up
2021-65.2% 37.5 pts down
2020-27.7% 33.7 pts up
2019-61.4%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on TMDX

TransMedics Group, Inc., figure by figure

TransMedics Group, Inc. (TMDX) overview: price, valuation and scorecard

TransMedics Group, Inc. return on equity (ROE): questions and answers

What is TransMedics Group, Inc.'s return on equity?

TransMedics Group, Inc. (TMDX) earned a return on equity of 40.2% in fiscal 2025 (the year ended December 31, 2025). That is 24.7 percentage points higher than the 15.5% of fiscal 2024.

Is TransMedics Group, Inc.'s return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in every one of the 6 earlier fiscal years on record, whose median is -23.5%.

What are the highest and lowest return on equity figures on record for TransMedics Group, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was 40.2% in fiscal 2025 and the lowest -65.2% in fiscal 2021.

How is TransMedics Group, Inc.'s return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “TransMedics Group, Inc. (TMDX) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/TMDX/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.